Influencing factors of the therapeutic effect of edaravone and dexborneol on acute ischemic stroke
Objective:To analyze the influencing factors of the therapeutic effect of edaravone and dexborneol on acute ischemic stroke(AIS).Methods:A total of 69 AIS inpatients admitted to our hospital from September 2021 to September 2022 were selected.They were treated by the intravenous injection of edaravone and dexborneol on the basis of routine AIS treatment.Logistic regression analysis was used to analyze the factors affecting the therapeutic effect of edaravone and dexborneol.Results:AIS patients were mostly over 70 years old and male.The majority of duration of medication was concentrated in the 5-9 days.Age,illness severity at admission,and duration of medication were the influencing factors of therapeutic effect of edaravone and dexborneol in the treatment of AIS(P＜0.05).Conclusion:The recommended duration of medication for edaravone and dexborneol is 10-14 days.For older and more severe AIS patients,it is suggested that edaravone and dexborneol should be combined with other methods for treatment as as soon as possible.
edaravone and dexborneolacute ischemic stroketherapeutic effectinfluencing factors
万方数据
